U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 2 of 2 results

OPROZOMIB

MORE DETAILS

  MZ37792Y8J

Status:
Investigational
Class (Stereo):
CHEMICAL (ABSOLUTE)
Targets:
Proteasome subunit beta type-5
5
Proteasome subunit beta type-8
3
Conditions:
Waldenström's macroglobulinemia
7
Multiple myeloma
159
Hepatocellular carcinoma
83
Oprozomib (PR-047) is an orally bioavailable derivative of carfilzomib, with similar biological activity, i.e. inhibition of the chymotrypsin-like activity of the proteasome. It inhibits the activity of the proteasome, thereby blocking the targeted p...

BAZLITORAN

MORE DETAILS

2U46M95B5M

nucleic acid
Status:
Investigational
Class:
NUCLEIC ACID
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966